BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11264243)

  • 1. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
    D'Alonzo AJ; Zhu JL; Darbenzio RB
    Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
    Dhein S; Perlitz F; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):631-44. PubMed ID: 18648775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
    Orosz S; Sarusi A; Csík N; Papp JG; Varró A; Farkas S; Forster T; Farkas AS; Farkas A
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):266-76. PubMed ID: 24887684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
    Cheng HC; Incardona J
    J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts.
    Dujardin KS; Dumotier B; David M; Guizy M; Valenzuela C; Hondeghem LM
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1414-21. PubMed ID: 18676685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
    Huang ZJ; Dai DZ; Li N; Na T; Ji M; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):310-7. PubMed ID: 17324143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.
    Farkas AS; Makra P; Csík N; Orosz S; Shattock MJ; Fülöp F; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2009 Mar; 156(6):920-32. PubMed ID: 19222480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.
    Tisdale JE; Jaynes HA; Overholser BR; Sowinski KM; Kovacs RJ
    J Cardiovasc Electrophysiol; 2019 Jun; 30(6):941-949. PubMed ID: 31006943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.
    Farkas AS; Rudas L; Makra P; Csík N; Leprán I; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Br J Pharmacol; 2010 Dec; 161(7):1477-95. PubMed ID: 20659107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers.
    Démolis JL; Martel C; Funck-Brentano C; Sachse A; Weimann HJ; Jaillon P
    Br J Clin Pharmacol; 1997 Oct; 44(4):403-9. PubMed ID: 9354317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.